Spine

NexCore Group and Montrose Regional Health Open New Ambulatory Care Center in Western Colorado

Retrieved on: 
Thursday, May 9, 2024

DENVER, May 9, 2024 /PRNewswire-PRWeb/ -- NexCore Group, a leading healthcare real estate development, investment, and management company, and Montrose Regional Health ("MRH"), celebrated the opening of a new Ambulatory Care Center ("ACC") in Montrose, Colorado on April 25, 2024.

Key Points: 
  • DENVER, May 9, 2024 /PRNewswire-PRWeb/ -- NexCore Group , a leading healthcare real estate development, investment, and management company, and Montrose Regional Health ("MRH"), celebrated the opening of a new Ambulatory Care Center ("ACC") in Montrose, Colorado on April 25, 2024.
  • "NexCore Group is thrilled to have partnered with Montrose Regional Health on this new Ambulatory Care Center.
  • The 3rd floor is exclusively leased to Cedar Point Health ("CPH"), the largest primary care provider group in the region.
  • "NexCore Group is thrilled to have partnered with Montrose Regional Health on this new Ambulatory Care Center.

Globus Medical Reports First Quarter 2024 Results

Retrieved on: 
Tuesday, May 7, 2024

AUDUBON, Pa., May 07, 2024 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal solutions company, today announced its financial results for the quarter ended March 31, 2024.

Key Points: 
  • AUDUBON, Pa., May 07, 2024 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal solutions company, today announced its financial results for the quarter ended March 31, 2024.
  • I am pleased with the first quarter results delivered by strong teamwork and partnership throughout our organization.
  • Globus Medical will hold a teleconference to discuss its first quarter 2024 results with the investment community at 4:30 p.m. Eastern Time today.
  • The audio archive will be available after the call on the Investor page of the Globus Medical website.

ClearPoint Neuro Reports First Quarter 2024 Results

Retrieved on: 
Tuesday, May 7, 2024

SOLANA BEACH, Calif., May 07, 2024 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (Nasdaq: CLPT) (the “Company”), a global device, cell, and gene therapy-enabling company offering precise navigation to the brain and spine, today announced financial results for its first quarter ended March 31, 2024.

Key Points: 
  • SOLANA BEACH, Calif., May 07, 2024 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (Nasdaq: CLPT) (the “Company”), a global device, cell, and gene therapy-enabling company offering precise navigation to the brain and spine, today announced financial results for its first quarter ended March 31, 2024.
  • “Our ClearPoint Neuro team enjoyed the best operating performance in our Company’s history, with contributions coming from all four of our growth pillars,” commented Joe Burnett, President and CEO at ClearPoint Neuro.
  • Financial Results – Quarter Ended March 31, 2024
    Total revenue was $7.6 million for the three months ended March 31, 2024, and $5.4 million for the three months ended March 31, 2023, which represents an increase of $2.2 million, or 41%.
  • Operating expenses for the first quarter of 2024 were $8.8 million, compared to $8.9 million for the first quarter of 2023.

SI-BONE Expands Portfolio with the Launch of New Offering for the iFuse Bedrock Granite Implant System and Completes Inaugural Surgical Procedures

Retrieved on: 
Tuesday, May 7, 2024

When placed across the SI joint, the Granite implant provides sacroiliac fusion and spinopelvic fixation as a foundational element for multi-segment spinal fusion.

Key Points: 
  • When placed across the SI joint, the Granite implant provides sacroiliac fusion and spinopelvic fixation as a foundational element for multi-segment spinal fusion.
  • The iFuse Bedrock Granite Implant System was awarded a Breakthrough Device Designation by the Food & Drug Administration and a New Technology Add-on Payment by the Centers for Medicare and Medicaid Services.
  • More importantly, even with complex reconstructions, as in my experience for my first Granite 9.5 case, the implant did not change my surgical workflow.
  • The S1 Granite 9.5 implants were a welcome addition to the 10.5 mm Granite implants I use for sacroalar-iliac fixation in my constructs.

Biogennix Receives FDA Clearance for Expanded Use of Agilon Moldable and Morpheus Moldable Products

Retrieved on: 
Wednesday, May 8, 2024

Irvine-based Biogennix , LLC an osteobiologics company specializing in bone graft products for fusion procedures, announced today that it has received U.S. Food and Drug Administration (FDA) 510(k) clearance for an expanded indication for its Agilon Moldable and Morpheus Moldable bone grafting products.

Key Points: 
  • Irvine-based Biogennix , LLC an osteobiologics company specializing in bone graft products for fusion procedures, announced today that it has received U.S. Food and Drug Administration (FDA) 510(k) clearance for an expanded indication for its Agilon Moldable and Morpheus Moldable bone grafting products.
  • Agilon Moldable is unique among moldable synthetic bone grafts, as it contains both collagen with an organic polymer carrier and Biogennix’s proprietary TrelCor granules.
  • "Receiving expanded indications for our flagship Agilon Moldable and Morpheus products is exciting news," said Chris MacDuff, Biogennix’s CEO.
  • Based on enthusiastic feedback from over 75,000 successful cases to date, we anticipate increased market adoption this year for both Agilon and Morpheus moldable products."

HealthTrust Introduces SurgIntel for Medical Device Management

Retrieved on: 
Wednesday, May 8, 2024

HealthTrust Performance Group , a leading performance improvement organization with an aligned healthcare membership model, has launched SurgIntel, an innovative source for medical device implant analytics.

Key Points: 
  • HealthTrust Performance Group , a leading performance improvement organization with an aligned healthcare membership model, has launched SurgIntel, an innovative source for medical device implant analytics.
  • Medical Device Management (MDM) is a HealthTrust value-added service built by operators and guided by physicians to help organizations go beyond pricing to capture value, cost-savings and physician alignment.
  • “SurgIntel's medical device implant database has the potential to revolutionize healthcare decision-making,” said Chris J. Stewart, Vice President of MDM for HealthTrust.
  • Empowering health systems with personalized cost-per-case information can optimize implant selection, eliminate unnecessary variation and lead to improved patient outcomes.

Atlantis Orthopedics Selects eClinicalWorks Cloud EHR and healow to Improve Practice Efficiency and Enhance Patient Care

Retrieved on: 
Tuesday, May 7, 2024

eClinicalWorks® , the largest ambulatory cloud EHR, today announced that Florida-based Atlantis Orthopedics, has selected eClinicalWorks Cloud EHR and healow® patient engagement solutions to streamline operations and improve patient engagement.

Key Points: 
  • eClinicalWorks® , the largest ambulatory cloud EHR, today announced that Florida-based Atlantis Orthopedics, has selected eClinicalWorks Cloud EHR and healow® patient engagement solutions to streamline operations and improve patient engagement.
  • By leveraging the intelligent eClinicalWorks Cloud EHR and healow patient engagement solutions, the practice can enhance the patient experience and improve overall practice efficiency.
  • “We selected eClinicalWorks for a fully integrated cloud EHR and patient engagement solutions, facilitating quick access to patient information and improving the patient experience.
  • eClinicalWorks is designed to help healthcare providers optimize resources, focus on patient care, and reduce costs.

Orthopedic & Spine Centers of Wisconsin Continues Its Growth Throughout Madison

Retrieved on: 
Wednesday, May 8, 2024

MADISON, Wis., May 8, 2024 /PRNewswire/ -- Long-time Madison podiatrist Colin Graney, DPM, has announced both the closing of his practice and that the Board Certified and Fellowship Trained physicians at Orthopedic & Spine Centers of Wisconsin will provide continuing care for his patients. Their comprehensive team specializes in all areas of orthopedics, including a dedicated foot & ankle specialty team led by Dr. Joseph Sizensky. Other areas of expertise include orthopedic surgery, sports medicine, hand & upper extremity care, joint replacement and spine care. Orthopedic & Spine Centers of Wisconsin has several locations throughout the area, including their main office located in the Arbor Gate Complex at 2501 W Beltline Hwy, Suite 601, Madison, WI, 53713.

Key Points: 
  • Other areas of expertise include orthopedic surgery, sports medicine, hand & upper extremity care, joint replacement and spine care.
  • Orthopedic & Spine Centers of Wisconsin has several locations throughout the area, including their main office located in the Arbor Gate Complex at 2501 W Beltline Hwy, Suite 601, Madison, WI, 53713.
  • "We are honored that physicians continue to entrust the care of their patients with our growing platform," said Dr. Jason Sansone, President of Orthopedic & Spine Centers of Wisconsin.
  • Now in its second year of operations, Orthopedic & Spine Centers of Wisconsin has continued its rapid growth across the region.

Electrosurgery Market to be Worth $8.99 Billion by 2031 - Exclusive Report by Meticulous Research®

Retrieved on: 
Wednesday, May 8, 2024

Additionally, factors such as rising healthcare expenditure and market expansion in emerging economies are expected to create market growth opportunities.

Key Points: 
  • Additionally, factors such as rising healthcare expenditure and market expansion in emerging economies are expected to create market growth opportunities.
  • However, the risks associated with electrosurgical procedures and the shortage of surgeons restrain the growth of this market.
  • The report also includes an extensive assessment of the key growth strategies adopted by leading market players over the past three years.
  • The global electrosurgery market has witnessed several product launches, product approvals, acquisitions, and expansions in the last couple of years.

Electrosurgery Market to be Worth $8.99 Billion by 2031 - Exclusive Report by Meticulous Research®

Retrieved on: 
Wednesday, May 8, 2024

Additionally, factors such as rising healthcare expenditure and market expansion in emerging economies are expected to create market growth opportunities.

Key Points: 
  • Additionally, factors such as rising healthcare expenditure and market expansion in emerging economies are expected to create market growth opportunities.
  • However, the risks associated with electrosurgical procedures and the shortage of surgeons restrain the growth of this market.
  • The report also includes an extensive assessment of the key growth strategies adopted by leading market players over the past three years.
  • The global electrosurgery market has witnessed several product launches, product approvals, acquisitions, and expansions in the last couple of years.